title: A geranyl acetophenone targeting cysteinyl leukotriene synthesis prevents allergic airway inflammation in ovalbumin-sensitized mice.
abstract: Asthma is associated with increased pulmonary inflammation and airway hyperresponsiveness. The current use of corticosteroids in the management of asthma has recently raised issues regarding safety and lack of responsiveness in 5-10% of asthmatic individuals. The aim of the present study was to investigate the therapeutic effect of a non-steroidal small molecule that has cysteinyl leukotriene (cysLT) inhibitory activity, upon attenuation of allergic lung inflammation in an acute murine model. Mice were sensitized with ovalbumin (OVA) and treated with several intraperitoneal doses (100, 20, 2 and 0.2mg/kg) of 2,4,6,-trihydroxy-3-geranylacetophenone (tHGA). Bronchoalveolar lavage was performed, blood and lung samples were obtained and respiratory function was measured. OVA sensitization increased pulmonary inflammation and pulmonary allergic inflammation was significantly reduced at doses of 100, 20 and 2mg/kg with no effect at the lowest dose of 0.2mg/kg. The beneficial effects in the lung were associated with reduced eosinophilic infiltration and reduced secretion of Th2 cytokines and cysLTs. Peripheral blood reduction of total IgE was also a prominent feature. Treatment with tHGA significantly attenuated altered airway hyperresponsiveness as measured by the enhanced pause (Penh) response to incremental doses of methacholine. These data demonstrate that tHGA, a synthetic non-steroidal small molecule, can prevent acute allergic inflammation. This proof of concept opens further avenues of research and development of tHGA as an additional option to the current armamentarium of anti-asthma therapeutics.
authors.affiliation: Department of Biomedical Science, Putra Malaysia, Serdang, Selangor, Malaysia.
authors.forename: Norazren
authors.initials: N
authors.lastname: Ismail
authors.forename: Nuzul Nurahya
authors.initials: NN
authors.lastname: Jambari
authors.forename: Seema
authors.initials: S
authors.lastname: Zareen
authors.forename: Mohamad Nadeem
authors.initials: MN
authors.lastname: Akhtar
authors.forename: Khozirah
authors.initials: K
authors.lastname: Shaari
authors.forename: Mohamad
authors.initials: M
authors.lastname: Zamri-Saad
authors.forename: Chau Ling
authors.initials: CL
authors.lastname: Tham
authors.forename: Mohd Roslan
authors.initials: MR
authors.lastname: Sulaiman
authors.forename: Nordin Hj
authors.initials: NH
authors.lastname: Lajis
authors.forename: Daud Ahmad
authors.initials: DA
authors.lastname: Israf
mesh_terms: D000098:Acetophenones / Q000494:pharmacology*; D000818:Animals; D018927:Anti-Asthmatic Agents / Q000494:pharmacology*; D001249:Asthma / Q000276:immunology / Q000378:metabolism / Q000517:prevention & control*; D016535:Bronchial Hyperreactivity / Q000276:immunology / Q000378:metabolism / Q000517:prevention & control*; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology / Q000276:immunology; D003545:Cysteine / Q000096:biosynthesis*; D016207:Cytokines / Q000378:metabolism; D006651:Histocytochemistry; D007073:Immunoglobulin E / Q000097:blood; D015289:Leukotrienes / Q000096:biosynthesis*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D010993:Plethysmography, Whole Body
chemical_list: D000098:Acetophenones; D018927:Anti-Asthmatic Agents; D016207:Cytokines; D015289:Leukotrienes; C112381:cysteinyl-leukotriene; D007073:Immunoglobulin E; D003545:Cysteine